GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Tax Provision

Concord Biotech (BOM:543960) Tax Provision : ₹-1,045 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Tax Provision?

Concord Biotech's tax provision for the six months ended in Mar. 2024 was ₹-592 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-1,045 Mil.


Concord Biotech Tax Provision Historical Data

The historical data trend for Concord Biotech's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Tax Provision Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Tax Provision
-445.26 -778.33 -625.89 -819.28 -1,044.62

Concord Biotech Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Tax Provision Get a 7-Day Free Trial - -226.37 -592.91 -452.27 -592.35

Concord Biotech Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-1,045 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Biotech (BOM:543960) Business Description

Traded in Other Exchanges
Address
Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines